Campbell's (NASDAQ:CPB - Get Free Report) had its target price dropped by stock analysts at BNP Paribas Exane from $22.00 to $19.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an "underperform" rating on the stock. BNP Paribas Exane's price objective indicates a potential downside of 8.49% from the company's previous close.
CPB has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of Campbell's from $23.00 to $20.00 and set a "hold" rating on the stock in a research report on Monday, March 30th. Stifel Nicolaus cut their price target on shares of Campbell's from $30.00 to $25.00 and set a "hold" rating on the stock in a research report on Thursday, March 12th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Campbell's in a research report on Thursday, April 2nd. UBS Group cut their price target on shares of Campbell's from $24.00 to $20.00 and set a "sell" rating on the stock in a research report on Friday, March 13th. Finally, Bank of America cut their price target on shares of Campbell's from $26.00 to $23.00 and set an "underperform" rating on the stock in a research report on Thursday, March 12th. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and eight have assigned a Sell rating to the stock. Based on data from MarketBeat, Campbell's currently has a consensus rating of "Reduce" and an average target price of $26.89.
Check Out Our Latest Report on CPB
Campbell's Trading Up 0.4%
NASDAQ CPB traded up $0.07 on Thursday, reaching $20.76. The company had a trading volume of 5,264,638 shares, compared to its average volume of 8,541,913. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.01 and a quick ratio of 0.51. The firm has a market cap of $6.19 billion, a price-to-earnings ratio of 11.34 and a beta of 0.03. The business has a 50 day moving average of $24.91 and a two-hundred day moving average of $27.90. Campbell's has a fifty-two week low of $20.32 and a fifty-two week high of $39.04.
Campbell's (NASDAQ:CPB - Get Free Report) last issued its quarterly earnings results on Wednesday, March 11th. The company reported $0.51 EPS for the quarter, missing analysts' consensus estimates of $0.57 by ($0.06). The firm had revenue of $2.56 billion for the quarter. Campbell's had a net margin of 5.48% and a return on equity of 19.96%. The company's revenue was down 4.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.74 earnings per share. Campbell's has set its FY 2026 guidance at 2.150-2.250 EPS. Analysts forecast that Campbell's will post 3.15 EPS for the current year.
Insider Activity
In other news, EVP Anthony Sanzio sold 2,700 shares of the stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $26.51, for a total transaction of $71,577.00. Following the transaction, the executive vice president owned 25,264 shares of the company's stock, valued at $669,748.64. This represents a 9.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 19.78% of the stock is owned by company insiders.
Hedge Funds Weigh In On Campbell's
A number of institutional investors and hedge funds have recently made changes to their positions in CPB. Stance Capital LLC bought a new position in shares of Campbell's during the 3rd quarter worth about $27,000. Flagship Harbor Advisors LLC bought a new position in shares of Campbell's during the 4th quarter worth about $29,000. Sittner & Nelson LLC bought a new position in shares of Campbell's during the 4th quarter worth about $29,000. Los Angeles Capital Management LLC acquired a new stake in shares of Campbell's in the 4th quarter worth about $29,000. Finally, Ankerstar Wealth LLC acquired a new stake in shares of Campbell's in the 4th quarter worth about $29,000. Institutional investors own 52.35% of the company's stock.
Campbell's Company Profile
(
Get Free Report)
Campbell's NASDAQ: CPB is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell's has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.
The company's brand portfolio includes Campbell's Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Campbell's, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Campbell's wasn't on the list.
While Campbell's currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.